Interleukin 8 (IL8) is usually produced in both epithelial and monocytic cells during bacterial infections, causing inflammation. Helicobacter pylori induces production of IL8 from gastric epithelial cells via its cag pathogenicity island (cag PAI) system, LPS and outer-membrane protein. In some bacteria, heat-shock protein 60 (HSP60) also elicits a strong pro-inflammatory response in cells of the innate immune system. Three recombinant H. pylori HSP60 (rHSP60) proteins of different sizes were produced and one of these was used to raise two monoclonal antibodies (2E7 and 7B5). IL8 production was found to be induced in cultured monocytic cells treated with H. pylori cells or rHSP60 proteins, as measured by ELISA, and the amount of IL8 produced was dosedependent. Pre-incubation of H. pylori cells or rHSP60 preparations with the antibody 2E7 significantly inhibited IL8 production from monocytic cells. These results indicated that HSP60 is closely associated with IL8 production in monocytic cells.
INTRODUCTION
Chronic infection with Helicobacter pylori is recognized as the cause of chronic active gastritis, peptic ulcer diseases and mucosa-associated lymphoid tissue (MALT) lymphoma and is an important risk factor for the development of gastric carcinoma (Blaser, 1990; Parsonnet et al., 1991 Parsonnet et al., , 1994 ). The chronic phase of H. pylori infection associates adaptive lymphocyte immunity with innate immunity. Colonization of H. pylori in the mucosa leads to local infiltration of neutrophils, macrophages (Ernst & Gold, 2000) and T and B cells specific for H. pylori antigens (D'Elios et al., 1997; Di Tommaso et al., 1995) . Chronic gastritis is initiated and maintained by cytokines that are secreted by gastric epithelial cells and macrophages. Interleukin 8 (IL8) is one of the principal mediators of the inflammatory response.
Initially, secretion of IL8 was reported from gastric epithelial cells co-cultured with live H. pylori (Crabtree et al., 1995) and it was later proposed that this reaction depended on the cag pathogenicity island (cag PAI) (Crabtree et al., 1999) . Recently, it was also reported that bacterial surface molecules such as LPS and heat-shock protein 60 (HSP60) of H. pylori are closely associated with gastric inflammation. LPS induced secretion of IL8 via toll-like receptor 4 on host epithelial cells (Su et al., 2003) . However, the biological activity of H. pylori LPS is lower than that of the LPS of other Gram-negative bacteria (Birkholz et al., 1993; Moran et al., 1992) .
H. pylori seems to bind to gastric epithelial cells and mucin via HSP60 (Huesca et al., 1996) , and adaptive immunity to HSP60 was induced in H. pylori-infected patients (Hayashi et al., 1998; Sharma et al., 1997) . We reported previously that development of lymphoid tissue in patients with MALT lymphoma was associated with HSP60 (Kobayashi et al., 1998) . Furthermore, we found that the IgG response to HSP60 was closely associated with gastric inflammation and the pathogenesis of MALT lymphoma (Ishii et al., 2001 ; Kawahara et al. 1999) . Studies in vitro have indicated that HSP60 induces IL8 from gastric epithelial cells (Yamaguchi et al., 1999) and IL6 from monocytes/macrophages (Gobert et al., 2004) . It has also been reported that the HSP60s of Mycobacterium tuberculosis, Campylobacter rectus and Chlamydia pneumoniae induce the production of IL8 by human monocytic cells, human gingival fibroblasts and human endothelial cells, respectively (Bulut et al., 2002; Flohe et al., 2003; Friedland et al., 1993; Hinode et al., 1998) . Therefore, we speculated that H. pylori HSP60 might be involved in the activation of macrophages.
To investigate the mechanisms of macrophage activation associated with HSP60, we prepared whole HSP60 (rHSPw; Met 1 -Met 545 ) and two partial domains (rHSP2, Glu 101 -Ser 200 , and rHSP4-5, Ile 300 -Gly 435 ) as GST fusion proteins and six peptides of the rHSP4-5 domain. Two monoclonal antibodies (mAbs) were also prepared by immunizing BALB/ c mice with rHSP4-5. It was found that IL8 was secreted from monocytic cells (U937 and NOMO-1) following treatment with rHSPw and rHSP4-5 as well as with H. pylori cells. IL8 induction was inhibited by one of the mAbs against HSP60.
METHODS
Bacterial strains and cell culture. H. pylori ATCC 43504 cells were cultured on brain heart infusion (BHI) agar (Becton Dickinson) supplemented with 7 % horse blood and incubated at 37 8C under microaerophilic conditions. After incubation for 5 days, bacteria were harvested in RPMI 1640 with 10 % fetal calf serum (FCS) to an OD 600 of 1 . 0 corresponding to approximately 1 3 10 8 c.f.u. ml À1 . Intact and heat-killed (60 8C for 30 min) bacterial cells were used to stimulate U937 cells.
H. pylori strain SS-1, Helicobacter felis and Helicobacter hepaticus (kindly provided by A. Lee, University of New South Wales, Sydney, Australia) were cultured on BHI agar supplemented with 7 % horse blood and incubated at 37 8C under microaerophilic conditions for 5 days. Campylobacter jejuni JCM 2013 were also cultured on BHI agar supplemented with 7 % horse blood and incubated at 37 8C under microaerophilic conditions for 48 h. Escherichia coli NIH-JC2, Salmonella enterica serotype Enteritidis strain IID 604, Salmonella enterica serotype Typhi strain IID 907, Pseudomonas aeruginosa IFO 3455, Proteus mirabilis (clinical isolate) and Citrobacter freundii (clinical isolate) were cultured on BHI agar for 24 h. Bacterial cells were collected from the agar plates and washed in PBS three times. Cells were disrupted with an ultrasonic sonicator (Astrason) and centrifuged at 20 000 g for 20 min. Supernatants were subjected to a protein assay (Bio-Rad). The soluble cell lysates were used as antigens for ELISA and Western blotting.
U937 (human macrophage-like) and NOMO-1 (human monocytic cell-like) cell lines (Japanese Collection of Research Bioresources) were maintained in RPMI 1640 supplemented with 10 % FCS, 50 U penicillin G sodium ml À1 and 50 ìg streptomycin sulfate ml À1 . Cultures were maintained at 37 8C in an atmosphere of 5 % CO 2 with 99 % humidity.
Cloning, expression and purification of recombinant protein. The amino acid sequence of H. pylori HSP60 was analysed using Genetix software and a search was done for T-cell epitopes and homology to human HSP60. Whole HSP60 (rHSPw; Met 1 -Met 545 ) and two partial domains (rHSP2, Glu 101 -Ser 200 , and rHSP4-5, Ile 300 -Gly 435 ) were designed and expressed as GST fusion proteins (Yamasaki et al., 2004) . Soluble fusion proteins expressed by the GST-HSP clones (rHSPw, rHSP2 and rHSP4-5) were purified by glutathione-Sepharose 4B (Amersham Pharmacia) affinity chromatography according to the manufacturer's instructions. To exclude the effects of trace amounts of LPS in the recombinant protein preparations, the endotoxin activity of rHSP60 preparations was determined using a Limulus amoebocyte lysate assay kit (BioWhittaker) according to the manufacturer's instructions. The preparations of rHSP2, rHSP4-5and rHSPw contained 20, 23, 30 endotoxin units (EU) (ìg protein) À1 , respectively.
Production of mAbs. mAbs against rHSP4-5 were prepared as previously reported with slight modifications (Oguma et al., 1984) . Female BALB/c mice (8 weeks old) were inoculated subcutaneously twice at 4-week intervals with 100 ìg rHSP4-5 mixed with Freund's incomplete adjuvant. Four weeks after the second injection, a booster dose of 8 ìg rHSP4-5 was injected intravenously. Three days later, the spleen was removed aseptically and dissociated into a single-cell suspension. The lymphocytes (10 8 cells) obtained were fused with P3 X63-Ag8-U1 myeloma cells (10 7 cells) using 50 % polyethylene glycol 4000 (Merck). Fused cells were plated into 96-well tissue-culture plates (CellStar) and grown in HAT medium (RPMI 1640 containing 0 . 1 mM hypoxanthine, 0 . 4 ìM aminopterin, 0 . 016 mM thymidine and 20 % FCS) at 37 8C. When colonies became visible macroscopically, culture supernatants were screened for the production of anti-rHSP4-5 Abs by ELISA using plates coated with the recombinant proteins. Ab-producing hybridomas were subcloned in 96-well tissue-culture plates by limiting dilution. RPMI 1640 supplemented with 15 % FCS and 5 % Briclone hybridoma cloning medium (Dainippon Pharmaceutical Co.) was used throughout the experiment. Ab production was checked by ELISA and positive clones were expanded in large-scale cultures. The cells (. 10 7 ) were collected and injected intraperitoneally into BALB/c mice that had been pre-treated 7 days earlier with pristane (0 . 3 ml). Ascitic fluid was collected and the mAbs were purified by DE52 (Whatman) ion-exchange chromatography. The classes and subclasses of mAbs obtained were determined with a mouse monoclonal typing kit (mouse MonoAB ID/SP kit; The Binding Site).
ELISA and Western blotting. The reactivity of mAbs to the rHSP60 preparations, bacteria and human cells was checked by ELISA and Western blotting. One microgram of recombinant protein or 5 ìg bacterial antigen in 100 ìl coating buffer (pH 9 . 6) was coated on to the wells of a 96-well microtitre plate and left overnight at 4 8C. The wells were blocked using PBS containing 10 % skimmed milk for 2 h at room temperature. Various concentrations of mAb were reacted for 2 h at room temperature and washed with PBS containing 0 . 05 % Tween 20. Peroxidase-labelled rabbit anti-mouse IgG (Dako) was then added and the plates were incubated for 2 h at room temperature. After washing, the wells were reacted with ABTS tablets (Roche) as a substrate. The A 405 was measured on a model 680 ELISA plate reader (Bio-Rad).
Bacterial lysates were subjected to SDS-PAGE and transferred to PVDF membranes (Millipore). After reaction with mAbs, the reaction was detected using peroxidase-labelled rabbit anti-mouse IgG (Dako) as the secondary Ab and by ECL Western blotting detection reagents (Amersham Pharmacia Biotech). The luminol reaction was detected with an LAS-1000 Mini Bio-imaging Analyser System (Fuji Photo Film).
IL8 production stimulated by bacteria and rHSP60 proteins. U937 and NOMO-1 cells (5 3 10 5 cells ml À1 ) were co-incubated with different concentrations of intact (live) or heat-killed H. pylori, or with the rHSP60s, in 96-well plates for 8 h. The experiment was conducted in triplicate for each concentration. Heat-killed H. pylori was prepared by heating intact H. pylori at 60 8C for 30 min before stimulation. IL8 in cell-culture supernatants was collected by centrifugation and assayed by ELISA using a human IL8 ELISA development kit (Techne). The concentration of IL8 was determined using a standard curve obtained with recombinant IL8. The detection limit of the ELISA was 31 pg ml À1 .
Real-time PCR for IL8 mRNA. Total RNA was isolated from U937 cells using RNAzol-B (Tel-Test). After DNase I (Invitrogen) treatment, cDNA was prepared using ReverTra Dash (Takara). Quantitative PCR analysis was performed on a LightCycler using the LightCycler primer set for human IL8 and G6PDH. Real-time PCR was carried out in 24 ìl consisting of 10 ìl cDNA sample, 10 ìl water, 2 ìl LightCycler primer set and 2 ìl LightCycler FastStart DNA master SybrGreen I. The reaction mixtures were loaded into capillary tubes and thermal cycling was carried out as follows: activation of hot-start Taq DNA polymerase at 95 8C for 10 min, followed by 40 cycles of 95 8C for 10 s, 68 8C for 10 s and 72 8C for 16 s. The DNA concentration was calculated using the LightCycler software and the IL8 : G6PDH ratio was calculated.
Inhibition of IL8 production by anti-HSP60 polyclonal and monoclonal Abs. Inhibition of the IL8-inducing activity of H. pylori by both polyclonal and monoclonal Abs was observed. Intact or heatkilled H. pylori cells suspended in RPMI 1640 without antibiotics (OD 600 ¼ 0 . 5) were incubated with an equal volume of IgG (100 ìg ml À1 in 10 mM PBS, pH 7 . 4) of anti-H. pylori polyclonal Ab (Yunoki et al., 2000) , anti-HSP60 mAbs (2E7 and 7B5) or control mAb (anti-type C botulinum toxin) for 30 min at 37 8C. The bacterial suspension (500 ìl) was then added to 500 ìl U937 or NOMO-1 cell culture (5 . 0 3 10 5 cells) and incubated for 5 h at 37 8C. The supernatants were used for the IL8 ELISA.
Production of synthetic peptide and ELISA. The domain of rHSP4-5 was divided into six fragments containing 20 or 23 amino acids (Table  1) . Each peptide was synthesized on an Applied Biosystems model 430A synthesizer using N-hydroxybenzotriazole esters of tert-butoxycarbonyl amino acids in an N-methylpyrrolidone solvent coupling system as described by the manufacturer. For induction of IL8 from U937 cells, synthetic peptides were added to the cell culture at a concentration of 100 ìg ml À1 . ELISA was performed as described above after coating 96-well microtitre plates with the peptides using a Peptide Coating kit (Takara Bio).
Statistical analysis. Results are expressed as means AE SEM. Data were compared using Scheffe's method and differences were considered significant for values of P , 0 . 05.
RESULTS
Intact and heat-killed H. pylori and rHSP60s induce IL8 production in monocytic cells IL8 production from U937 and NOMO-1 cells was analysed following treatment with various amounts of intact or heatkilled H. pylori or with the rHSP60 preparations. Intact or heat-killed H. pylori induced secretion of IL8 from U937 cells in a dose-dependent manner (Fig. 1a, b) . Intact H. pylori stimulation using .1 3 10 6 c.f.u. ml À1 induced significant levels of IL8 production. Low concentrations of heat-killed H. pylori induced low levels of IL8 production, but high concentrations (.5 3 10 7 c.f.u. ml À1 ) of heat-killed H. pylori induced IL8 production at levels comparable with intact H. pylori stimulation. Production of IL8 from stimulated NOMO-1 cells showed the same trend (Fig. 1c, d ).
Cells treated with 1-200 ìg rHSP4-5 or rHSPw ml À1 also released IL8. rHSPw and rHSP4-5 preparations induced IL8 production from U937 and NOMO-1 cells in a dosedependent manner (Fig. 2a, b) . IL8 secretion was increased significantly by the addition of more than 25 ìg rHSPw or 50 ìg rHSP4-5 ml À1 in U937 cells. However, IL8 secretion induced by rHSP2 was lower than that of rHSPw and rHSP4-5. A polymyxin B (PMB)-agarose gel column (Pierce Biotechnology) was used to remove LPS and LPS-associated molecules in the preparation (Gao & Tsan, 2003) . The concentration of LPS in the PMB-agarose column passthrough fractions was less than 10 EU (2 mg protein) À1 (Takenaka et al. 2004 ). IL8 secretion from U937 and NOMO-1 cells was not induced by stimulation with 10 EU E. coli LPS (Sigma), although LPS contamination is not associated with this experiment. mRNA expression stimulated by rHSP60 U937 cells (5 3 10 5 cells ml À1 ) were stimulated with intact H. pylori (1 3 10 6 c.f.u. ml À1 ), heat-killed H. pylori (5 3 10 6 cell ml À1 ) or rHSPw (100 ìg ml À1 ) and the culture supernatant was collected at various times between 1 and 24 h. IL8 production induced by rHSPw increased from 1 to 9 h, reaching a plateau at 9 h (Fig. 3a) . Real-time PCR was used for IL8 mRNA expression in U937 cells. Expression of IL8 mRNA was maximal at 1 h and continued for the following 12 h (Fig. 3b) .
Characterization of anti-rHSP4-5 mAbs
Two mAbs (2E7 and 7B5) were obtained. They were classified as IgG2b. The reaction of these mAbs to different rHSP60 preparations and bacterial cell lysates was determined by ELISA. The mAbs reacted with rHSPw and rHSP4-5, but not with rHSP2 or human rHSP60 (Stressgen). Data for 2E7 are shown in Fig. 4(a) ; comparable results were obtained for 7B5. 2E7 and 7B5 did not react with E. coli, S. Enteritidis, S. Typhi, Pseudomonas aeruginosa, Proteus mirabilis and Citrobacter freundii in ELISA and Western blotting (data not shown). mAb 2E7 reacted with H. pylori, H. felis, Campylobacter jejuni and H. hepaticus (Fig. 4b) , whereas 7B5 reacted only with H. pylori (Fig. 4c) . These results were also confirmed by Western blotting (Fig. 4d) .
Anti-HSP60 mAb inhibits IL8 production by monocytic cells
Intact or heat-killed H. pylori cells were incubated with anti-H. pylori polyclonal IgG, anti-rHSP4-5 mAbs (2E7 and 7B5) or control mAb (anti-type C botulinum toxin) and then coincubated with U937 or NOMO-1 cells. The concentration of IL8 in the supernatants was assayed after co-incubation for 8 h. Anti-H. pylori polyclonal Ab and anti-rHSP4-5 mAb (2E7) significantly inhibited IL8 production induced by both intact and heat-killed H. pylori (Fig. 5a ). mAb 2E7 inhibited IL8 production stimulated by both intact and heat-killed H. pylori, but 7B5 inhibited IL8 production stimulated by only intact H. pylori (Fig. 5b) . mAb 2E7 significantly inhibited IL8 production stimulated with rHSPw (68 . 2 % inhibition) and rHSP4-5 (57 . 4 % inhibition). Effective inhibition by 7B5 was not observed following stimulation with rHSP60w and rHSP4-5 (Fig. 5c ).
Reactivity of mAbs to synthetic peptides and peptide induction of IL8
The reaction of synthetic peptides covering the rHSP4-5 domain (peptides A-F; Table 1 ) to the two mAbs was examined. mAb 7B5 reacted strongly with peptides E and F but weakly with peptide A, whereas 2E7 reacted strongly with peptides A and D (Table 2 ). The amino acid sequences of peptides A, B and F are not identical to that of human HSP60 (Table 1 ). In the induction using these six peptides, only peptide A induced production of IL8 significantly in U937 cells. Peptide B induced a lower level of IL8 production, whereas peptide F did not induce IL8 production (Table 2) . 
DISCUSSION
We investigated whether HSP60 induced the production of IL8 by monocytic cells. Induction of IL8 was observed following stimulation not only with rHSPw but also with rHSP4-5, indicating that the region Ile 300 -Gly 435 of HSP60 is associated with induction of IL8 in monocytic cells. This was confirmed using two mAbs (2E7 and 7B5) prepared by immunizing mice with rHSP4-5. Both Abs reacted with rHSPw and rHSP4-5, but not with rHSP2 or human rHSP60, and significantly reduced the IL8-inducing activity. However, their inhibitory effects were different; 2E7 had a greater effect than 7B5 and inhibited the production of IL8 stimulated by both intact and heat-killed cells, while 7B5 only inhibited the production of IL8 induced by intact H. pylori. mAb 2E7 reacted with peptides A and D of rHSP4-5, whereas 7B5 reacted strongly with peptides E and F, but weakly with peptide A. It was thus concluded that the epitopes recognized by the two mAbs are different. It was not clear why the mAbs reacted with more than one peptide, but this may explain the differences in their inhibitory effects on IL8 production.
Peptide A induced IL8 production in U937 cells compared with peptides B-F, although the level of IL8 was not very high. The amino acid sequences of peptides A, B and F are quite different from that of human HSP60, whereas peptides C, D and E possess similar amino acid sequences to human HSP60. Therefore, it was speculated that the amino acid sequence differences compared with human HSP60, specifically in peptide A, are important for IL8 induction. Monocytic cells may recognize a bacteria-specific sequence or particular conformation of this region and thus induce production of a pro-inflammatory cytokine. mAb 7B5 reacted strongly with the synthetic peptides in ELISA. However, IL8 secretion was only weakly inhibited, or not inhibited, by 7B5 in heat-killed H. pylori or rHSP60 stimulations. In contrast, 2E7 had low reactivity to the peptides, but showed high levels of inhibition of IL8 production. Stimulation with the synthetic peptides induced low levels of IL8 production. In fact, recombinant proteins lost this activity if subjected to several freeze-thaw steps (data not shown), indicating that not only the amino acid Fig. 3 . Induction of IL8 mRNA stimulated by rHSP60. (a) U937 cells were stimulated with 2 3 10 6 cells of intact (e) or heat-killed (s) H. pylori ml À1 or 100 ìg rHSPw ml À1 (e). Samples were collected at 0, 1, 3, 6, 9 and 24 h and IL8 concentration was measured by ELISA. (b) mRNA expression was assayed using real-time PCR. U937 cells were stimulated with 100 ìg rHSPw ml À1 and collected at 0, 0 . 5, 1, 3, 6 and 12 h. The IL8 : G6PDH mRNA expression ratio at each time point was calculated.
sequence but also secondary protein structure or the threedimensional structure of the protein on the bacterial surface may be important for IL8 production.
IL8 is a pro-inflammatory cytokine, the actions of which are reported to include neutrophil and T-lymphocyte chemotaxis, neutrophil activation and enhanced expression of neutrophil adhesion molecules (Sherry & Cerami, 1991) . IL8 is released from gastric epithelial cells following stimulation with cag PAI and LPS of H. pylori. In this study, we demonstrated that IL8 was induced in U937 and NOMO-1 cells following stimulation not only with live H. pylori cells but also with heat-killed cells. This indicated that the production of IL8 is different from that associated with the Cag A and type IV secretion systems, which are formed only in living H. pylori cells. IL8 production was also induced by rHSP60 that had been passed through a column eliminating LPS. Other reports have indicated that not only cag PAI, but also flagella and the LPS, outer-membrane protein and HSP60 of H. pylori are associated with IL8 induction from epithelial cells or monocytes (Bhattacharyya et al., 2002; Cunningham et al., 2000; Lee et al., 2003; Yamaoka et al., 2000; Yamasaki et al., 2004) . These non-cag antigens are located on the bacterial surface and have direct contact with host cells. The cag-independent pathway of cytokine induction also may involve inducing mucosal inflammation. Therefore, we concluded that HSP60 is an important molecule for the IL8-inducing system in H. pylori infection.
It is still not clear how the immune system recognizes H. pylori early in infection and reacts to the bacteria in the stomach, since MALT does not normally exist in the stomach. Usually, immune responses arise specifically from within organized lymphoid tissue in the intestine (mostly located in the terminal ileum as Peyer's patches) (Wotherspoon, 1998) . It seems that H. pylori is not able to survive in the human intestine. We have demonstrated here that heat-killed H. pylori induced IL8 production by mono- cytic cells through HSP60. This supports the hypothesis that a bacterial surface component such as HSP60 on H. pylori that has flowed from the stomach into the intestine may activate immune responses through lymphoid tissue such as Peyer's patches. Some reports have indicated that cell-surface receptors are associated with the recognition of human HSP (Curry et al., 2003; MacDonald et al., 2002; Wang et al., 2002) . The receptors on monocytic cells for H. pylori HSP60 have still to be identified. We are now trying to identify the cell receptor for HSP60 and are also studying IL8 induction in gastric epithelial cells using H. pylori and rHSP60 preparations.
The Abs to specific sites recognizing HSP60 sequences of H. pylori that were different from human HSP60 inhibited IL8 production. Thus, we believe that specific domains of H. pylori HSP60 could be used as effective vaccines for antiinflammatory therapy in the future.
